Hospital

The newest indication is the first approval of pembrolizumab for breast cancer, according to Merck.

Glenmark Pharmaceutical’s tacrolimus drug product is the generic version of Astellas Pharma’s Prograf Capsules.

Even in a relatively asymptomatic case of COVID-19, it is possible that the virus could have fostered retrograde reactivation of the varicella-zoster virus.

Pfizer and BioNTech plan for submission to the FDA for an Emergency Use Authorization soon after the required safety milestone is achieved in mid-November for a promising novel COVID-19 vaccine candidate.

Further research is essential in order to determine the relationship between diabetes and COVID-19 and what impact glucose-lowering drugs may have.

Research suggests global access to COVID-19 vaccines is best for both global health and finances.

The FDA granted breakthrough therapy designation to dupilumab in September 2020, for the treatment of patients age 12 years and older with eosinophilic esophagitis.

Pharmacy students answered the question “Have you been able to build a professional pharmacy network during the pandemic?” The video is one part in the Pharmacy Times Student Café series.

Data show that children with cancer who are experiencing neighborhood poverty and rely on public health insurance have an increased risk of death with stem cell treatment.

Study suggests COVID-19 cases and deaths in the United States in the fall and winter will far exceed those of spring 2020 unless there is effective implementation of nationally coordinated efforts and preventive strategies.

Divergent research findings come as investigators seek to understand whether plasma treatments are effective in patients with COVID-19.

Today, we’re celebrating the pharmacy team at Encompass Health Rehabilitation Hospital of Desert Canyon in Las Vegas, Nevada.

The impact of engineering controls, such as ventilation systems, is greater on limiting the spread of COVID-19 than the impact of the most widely applied measures.

The relationship between the flu and heart disease is of particular concern during the pandemic, as severe COVID-19 outcomes have also been associated with exacerbated cardiovascular conditions.

Gilead Sciences' remdesivir is the first drug to receive FDA approval for treating COVID-19 in the United States.

Study shows that more than half of older patients hospitalized for heart failure are discharged with 10 or more prescriptions, putting them at significant risk for harm related to high medication burden.

The trial’s main goal is to compare the health status of participants in the combination treatment group with participants in the remdesivir-only group on day 7.

Sirolimus is an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection.

Evidence-based cancer regimens have been shown to result in better outcomes, including longer survival and less toxicity.

Heart attack, stroke, stent placement, or heart failure hospitalization occurred in 5.3% of the telemonitored group compared with 10.4% of the routine primary care group.

Researchers found that the children of women with preeclampsia had higher systolic blood pressure on average.

Although earlier research has shown slight reductions in opioid abuse rates, this analysis is the first to show statistically significant year-to-year declines.

This yearlong campaign recognizes pharmacists for their dedication, and often overlooked contributions, to transforming health care.

To celebrate American Pharmacists Month, Pharmacy Times spoke with several pharmacists about their experiences during the COVID-19 pandemic and how they have tackled its unique challenges.

In pharmacy management, a ‘one-size-fits-all’ approach might not be the most appropriate for providing performance feedback during formal review sessions.

It is especially important to better understand the interactions between COVID-19 and acute respiratory distress syndrome.

This week’s pharmacy management Tip of the Week takes a look at establishing a clinical pharmacy site in the emergency department (ED) of a hospital.

There is a new study that discovered certain drugs cause problems in healthy people who do not have risk factors or family members with dementia.

Contrary to earlier statements from the CDC, study suggests corticosteroid inhalers used by many asthmatics might make it more difficult for COVID-19 to enter the airways.

The action is part of a growing movement to expand the ability of pharmacists and pharmacy staff to meet the needs of patients during the COVID-19 pandemic.